These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11965376)

  • 1. Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesis.
    Smith RA; Hertzog DL; Osterhout MH; Ladouceur GH; Korpusik M; Bobko MA; Jones JH; Phelan K; Romero RH; Hundertmark T; MacDougall ML; Livingston JN; Schoen WR
    Bioorg Med Chem Lett; 2002 May; 12(9):1303-6. PubMed ID: 11965376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists.
    Ladouceur GH; Cook JH; Hertzog DL; Jones JH; Hundertmark T; Korpusik M; Lease TG; Livingston JN; MacDougall ML; Osterhout MH; Phelan K; Romero RH; Schoen WR; Shao C; Smith RA
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3421-4. PubMed ID: 12419375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist.
    Lin NH; Gunn DE; Li Y; He Y; Bai H; Ryther KB; Kuntzweiler T; Donnelly-Roberts DL; Anderson DJ; Campbell JE; Sullivan JP; Arneric SP; Holladay MW
    Bioorg Med Chem Lett; 1998 Feb; 8(3):249-54. PubMed ID: 9871663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 5-hydroxyalkyl-4-phenylpyridines as a new class of glucagon receptor antagonists.
    Ladouceur GH; Cook JH; Doherty EM; Schoen WR; MacDougall ML; Livingston JN
    Bioorg Med Chem Lett; 2002 Feb; 12(3):461-4. PubMed ID: 11814820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
    Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
    Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent.
    Kiyama R; Fuji M; Hara M; Fujimoto M; Kawabata T; Nakamura M; Fujishita T
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):450-60. PubMed ID: 7774028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 2-arylfuro[3,2-b]pyridines: Effect of the C2-aryl group on melatoninergic activity.
    Couhert A; Delagrange P; Caignard DH; Chartier A; Suzenet F; Guillaumet G
    Eur J Med Chem; 2016 Feb; 109():268-75. PubMed ID: 26785296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line.
    Midzak A; Denora N; Laquintana V; Cutrignelli A; Lopedota A; Franco M; Altomare CD; Papadopoulos V
    Eur J Pharm Sci; 2015 Aug; 76():231-7. PubMed ID: 26002041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Activity relationships of 2-substituted 5,7-Diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acids as a novel class of endothelin receptor antagonists.
    Niiyama K; Takahashi H; Nagase T; Kojima H; Amano Y; Katsuki K; Yamakawa T; Ozaki S; Ihara M; Yano M; Fukuroda T; Nishikibe M; Ishikawa K
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3041-5. PubMed ID: 12372497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted imidazoles as glucagon receptor antagonists.
    Chang LL; Sidler KL; Cascieri MA; de Laszlo S; Koch G; Li B; MacCoss M; Mantlo N; O'Keefe S; Pang M; Rolando A; Hagmann WK
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2549-53. PubMed ID: 11549467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 3H-[1,2,3]triazolo[4,5-c]pyridine derivatives as GPR119 agonists: Synthesis and structure-activity/solubility relationships.
    Matsuda D; Kobashi Y; Mikami A; Kawamura M; Shiozawa F; Kawabe K; Hamada M; Nishimoto S; Kimura K; Miyoshi M; Takayama N; Kakinuma H; Ohtake N
    Bioorg Med Chem; 2017 Aug; 25(16):4339-4354. PubMed ID: 28662959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of 5-substituted pyridine analogues of 3.
    Lin NH; Li Y; He Y; Holladay MW; Kuntzweiler T; Anderson DJ; Campbell JE; Arneric SP
    Bioorg Med Chem Lett; 2001 Mar; 11(5):631-3. PubMed ID: 11266158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-6-phosphatase catalytic enzyme inhibitors: synthesis and in vitro evaluation of novel 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines.
    Madsen P; Lundbeck JM; Jakobsen P; Varming AR; Westergaard N
    Bioorg Med Chem; 2000 Sep; 8(9):2277-89. PubMed ID: 11026540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
    Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Kingsbury WD
    J Med Chem; 1993 Oct; 36(22):3321-32. PubMed ID: 8230122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrano-[2,3b]-pyridines as potassium channel antagonists.
    Finlay HJ; Lloyd J; Nyman M; Conder ML; West T; Levesque P; Atwal K
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2714-8. PubMed ID: 18374568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)thieno[2,3-c]pyridines with fine-tuning at C-2 carbamides.
    Zhu GD; Arendsen DL; Gunawardana IW; Boyd SA; Stewart AO; Fry DG; Cool BL; Kifle L; Schaefer V; Meuth J; Marsh KC; Kempf-Grote AJ; Kilgannon P; Gallatin WM; Okasinski GF
    J Med Chem; 2001 Oct; 44(21):3469-87. PubMed ID: 11585452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel pyrazolo[1,5-a]pyridine-based EP
    Nishigaya Y; Umei K; Saito Y; Watanabe H; Kondo T; Kondo A; Kawamura N; Tatani K; Kohno Y; Tanaka N; Seto S
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4044-4050. PubMed ID: 28784294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel substituted pyridines as inhibitors of endothelin converting enzyme-1 (ECE-1).
    Massa MA; Patt WC; Ahn K; Sisneros AM; Herman SB; Doherty A
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2117-22. PubMed ID: 9873497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.
    Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
    J Med Chem; 1993 Dec; 36(26):4230-8. PubMed ID: 8277505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
    Wang H; Ruan Z; Li JJ; Simpkins LM; Smirk RA; Wu SC; Hutchins RD; Nirschl DS; Van Kirk K; Cooper CB; Sutton JC; Ma Z; Golla R; Seethala R; Salyan ME; Nayeem A; Krystek SR; Sheriff S; Camac DM; Morin PE; Carpenter B; Robl JA; Zahler R; Gordon DA; Hamann LG
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3168-72. PubMed ID: 18485702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.